UBS Group’s OncoSec Medical Incorporated ONCS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-8,253
| Closed | -$13.9K | – | 10126 |
|
2022
Q4 | $13.9K | Buy |
+8,253
| New | +$13.9K | ﹤0.01% | 6939 |
|
2022
Q2 | – | Sell |
-372
| Closed | -$9K | – | 10512 |
|
2022
Q1 | $9K | Buy |
+372
| New | +$9K | ﹤0.01% | 7578 |
|
2021
Q3 | – | Sell |
-117
| Closed | -$7K | – | 9478 |
|
2021
Q2 | $7K | Buy |
117
+69
| +144% | +$4.13K | ﹤0.01% | 7310 |
|
2021
Q1 | $5K | Sell |
48
-84
| -64% | -$8.75K | ﹤0.01% | 7353 |
|
2020
Q4 | $19K | Sell |
132
-114
| -46% | -$16.4K | ﹤0.01% | 5991 |
|
2020
Q3 | $18K | Buy |
+246
| New | +$18K | ﹤0.01% | 5551 |
|
2020
Q2 | – | Sell |
-364
| Closed | -$10K | – | 7660 |
|
2020
Q1 | $10K | Buy |
364
+322
| +767% | +$8.85K | ﹤0.01% | 6054 |
|
2019
Q4 | $2K | Sell |
42
-5
| -11% | -$238 | ﹤0.01% | 6825 |
|
2019
Q3 | $2K | Buy |
47
+6
| +15% | +$255 | ﹤0.01% | 6830 |
|
2019
Q2 | $2K | Sell |
41
-110
| -73% | -$5.37K | ﹤0.01% | 6808 |
|
2019
Q1 | $19K | Buy |
151
+53
| +54% | +$6.67K | ﹤0.01% | 5543 |
|
2018
Q4 | $14K | Buy |
98
+91
| +1,300% | +$13K | ﹤0.01% | 6148 |
|
2018
Q3 | $2K | Sell |
7
-44
| -86% | -$12.6K | ﹤0.01% | 6863 |
|
2018
Q2 | $16K | Buy |
51
+44
| +629% | +$13.8K | ﹤0.01% | 5951 |
|
2018
Q1 | $3K | Buy |
7
+5
| +250% | +$2.14K | ﹤0.01% | 6584 |
|
2017
Q4 | $1K | Hold |
2
| – | – | ﹤0.01% | 6792 |
|
2017
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 7040 |
|
2017
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 6616 |
|
2017
Q1 | $1K | Sell |
2
-20
| -91% | -$10K | ﹤0.01% | 6582 |
|
2016
Q4 | $6K | Buy |
22
+19
| +633% | +$5.18K | ﹤0.01% | 6211 |
|
2016
Q3 | $1K | Sell |
3
-12
| -80% | -$4K | ﹤0.01% | 6617 |
|
2016
Q2 | $6K | Sell |
15
-2
| -12% | -$800 | ﹤0.01% | 6169 |
|
2016
Q1 | $9K | Buy |
17
+15
| +750% | +$7.94K | ﹤0.01% | 5893 |
|
2015
Q4 | $1K | Buy |
2
+1
| +100% | +$500 | ﹤0.01% | 6763 |
|
2015
Q3 | $1K | Sell |
1
-16
| -94% | -$16K | ﹤0.01% | 6748 |
|
2015
Q2 | $24K | Buy |
+17
| New | +$24K | ﹤0.01% | 5376 |
|